CVE-2015-3965: Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated op

Q: How do I fix CVE-2015-3965?

symbiq infusion system firmware: upgrade to newer than 3.13. Exact commands for each OS are on this page.

Q: Is CVE-2015-3965 being exploited?

CVE-2015-3965 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.

Q: What does CVE-2015-3965 affect?

CVE-2015-3965 affects symbiq infusion system firmware. Severity is high (CVSS 8.8). Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.

This month

HIGH 8.8UPGRADE

CVE-2015-3965 is a high-severity flaw (CVSS 8.8) affecting symbiq infusion system firmware. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.

Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.

Why this priority

High severity

A fixed release or distro patch exists.

Risk facts

CVSS score	8.8 (High)
Attack vector	Network (remote)
Attack complexity	Low
Privileges needed	Low
User interaction	None
EPSS exploit chance	2.9% (top 13%)
CISA exploited list	No
Weakness	CWE-264
Published	2019-03-23
Last modified	2026-06-17

Publisher (CNA): ICS-CERT · Vendor: pfizer

Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score

Am I affected?

Timeline

2019-03-23 20:29 UTCPublished CVE record published
2026-06-17 00:26 UTCUpdated Record last modified

pfizer symbiq infusion system firmware UPGRADE

Affected: <= 3.13

Fixed in: newer than 3.13

Safe to downgrade to: no unaffected older release

Check your OS release

cat /etc/os-release; uname -r

Debian / Ubuntu

sudo apt update && sudo apt full-upgrade

RHEL / Amazon Linux / Fedora

sudo dnf upgrade --refresh

Windows

Install the latest cumulative update from Windows Update

If no patch exists yet

OS downgrades are not safe. Apply the vendor mitigation from the advisory and restrict exposure.

Verify at the official source NVD · CVE Program · Report a problem with this page
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.

Quick answers

How do I fix CVE-2015-3965?

symbiq infusion system firmware: upgrade to newer than 3.13. Exact commands for each OS are on this page.

Is CVE-2015-3965 being exploited?

CVE-2015-3965 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.

What does CVE-2015-3965 affect?

CVE-2015-3965 affects symbiq infusion system firmware. Severity is high (CVSS 8.8). Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.

How urgent is CVE-2015-3965?

Priority 53/100. High severity

Related CVEs

CVE-2015-3956 CRITICAL 9.8 UPGRADE UPGRADE Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and S
CVE-2015-3954 CRITICAL 9.8 UPGRADE UPGRADE Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and S
CVE-2015-3953 CRITICAL 9.8 UPGRADE UPGRADE Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Inf
CVE-2015-3952 HIGH 7.5 UPGRADE UPGRADE Wireless keys are stored in plain text on Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Inf

References

← Back to latest CVEs